PHLPP2 and pachyonychia congenita: The upregulation of miR-25-3p inhibits PHLPP2 and activates AKT-p70S6K oncogenic signaling, forming a malignant METTL3–miR-25-3p–PHLPP2–AKT axis and promoting PC development and progression (13).